A comparative study of albumin bilirubin score, with meld for predicting the in-hospital mortality in cirrhotic patients complicated with upper gastrointestinal bleeding in a tertiary care hospital

Parmendra Kumar Prajapati; Basudev Prasad Priyadarshi; Ashaq Hussain Dar

doi:10.18203/2349-3933.ijam20243819

Authors

Parmendra Kumar Prajapati Department of Medicine, GSVM Medical College, Kanpur Uttar Pradesh, India
Basudev Prasad Priyadarshi Department of Medicine, GSVM Medical College, Kanpur Uttar Pradesh, India
Ashaq Hussain Dar Department of Medicine, GSVM Medical College, Kanpur Uttar Pradesh, India

DOI:

https://doi.org/10.18203/2349-3933.ijam20243819

Keywords:

Albumin bilirubin score, Acute upper gastrointestinal bleed, Model for end stage liver disease chronic liver disease, Receiver operating characteristic curve

Abstract

Background: Chronic liver disease (CLD) encompasses a spectrum of injury from simple steatosis to frank cirrhosis which is evaluated by many scoring systems. Aim of the study was to evaluate the discriminative abilities of model for end-stage liver disease (MELD) score and albumin-bilirubin (ALBI) score in predicting the in-hospital mortality in cirrhotic patients complicated with upper gastrointestinal bleeding.

Methods: Data of patients with liver cirrhosis secondary to ethanol, hepatitis B and hepatitis C and cryptogenic liver cirrhosis, with upper gastrointestinal bleed was prospectively reviewed from admission to date of discharge. MELD and ALBI score, calculated for the patient from ROC curves were analysed.

Results: Our study was conducted on 149 patients. Age distribution was between 18-80 years with mean age of patients being 44.7±12.37 years, male to female sex ratio 127:22, with mortality calculated at 23.5%. The MELD score demonstrated a high predictive accuracy with an area under ROC curve of 0.953, with a 95% confidence interval ranging from 0.903 to 1.000. In contrast, ALBI score showed a lower predictive accuracy with an area under the ROC curve (AUROC) of 0.672 and 95% confidence interval ranging from 0.577 to 0.766.

Conclusions: The prognostic performance of two scores was comparable but MELD score was found to have a better prognostic significance than ALBI score.

Metrics

Metrics Loading ...

References

Child CG, Turcotte JG. Surgery and portal hypertension. Major Probl Clin Surg 1964;1:1-85.

Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973;60:646-9.

Child CG, Turcotte JG. Surgery and portal hypertension. In: Child CG (editor): The liver and portal hypertension. Saunders: Philadelphia; 1964: 50-64.

Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts.Hepatol. 2000;31:864-71.

Wiesner R, Edwards E, Freeman R. United network for organ sharing liver disease severity score committee. model organ sharing Liver Disease Severity Score Committee. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterol. 2003;124:91-6.

Londoño MC, Cárdenas A, Guevara M. MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation. Gut. 2007;56:1283-90.

Biggins SW, Rodriguez HJ, Bacchetti P, Bass NM, Roberts JP. Serum sodium predicts mortality in patients listed for liver transplantation. Hepatol. 2005;41:32-9.

Biggins SW, Kim WR, Terrault NA. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterol. 2006;130:1652-60.

Zou D, Qi X, Zhu C. Albumin-bilirubin score for predicting the in-hospital mortality of acute upper gastrointestinal bleeding in liver cirrhosis: A retrospective study. Turk J Gastroenterol 2016;27:180-6.

Chan AW, Chan RC, Wong GL. New simple prognostic score for primary biliary cirrhosis: Albumin-bilirubin score. J Gastroenterol Hepatol. 2015;30:1391-6.

Johnson PJ, Berhane S, Kagebayashi C. Assessment of liver function in patients with hepatocellular carcinoma: a new evidencebased approach-the ALBI grade. J Clin Oncol. 2015;33:550-8.

Toyoda H, Lai PB, O’Beirne J. Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI grade. Br J Cancer. 2016;114:744-50.

Sarangapanis, Bronte F, Conte E. Modified spleen stiffness measurement by transient elastography is associated with presence of large oesophageal varices in patients with compensated hepatitis C virus cirrhosis. J Viral Hepat. 2013;20(12):867-74.

Shao L, Han B, Shu AN, Jiaxin Ma, Xiaohong Guo, Romeiro FG, et al. Albumin-to-Bilirubin Score for Assessing the in-Hospital Death in Cirrhosis. Transl Gastroenterol Hepatol 2017;2:88.

Zou D, Qi X, Zhu C, Ning Z, Hou F, Zhao J. Albumin-bilirubin score for predicting the in-hospital mortality of acute upper gastrointestinal bleeding in liver cirrhosis: A retrospective study. The Turkish J Gastroenterol. 2016; 27(2):180-6.

Xavier SA, Vilas Boas R, Boal Carvalho P, Magalhaes. Assessment of prognostic performance of albumin bilirubin, child pugh and model for end stage Liver disease scores in patients complicated with Acute upper gastrointestinal bleeding. The European J Gastroenterol and Hepatol, 2018;30(6):652-8.